SG/CALL/SARTORIUS STEDIM BIO/340/0.025/21.03.25 Stock

Warrant

4R87S

DE000SW7VNR9

Real-time Euronext Paris 03:38:30 2024-05-15 am EDT
0.255 EUR 0.00% Intraday chart for SG/CALL/SARTORIUS STEDIM BIO/340/0.025/21.03.25
Current month+4.08%
1 month-60.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-15 0.255 0.00%
24-05-14 0.255 +13.33%
24-05-13 0.225 -4.26%
24-05-10 0.235 0.00%
24-05-09 0.235 0.00%

Real-time Euronext Paris

Last update May 15, 2024 at 03:38 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
4R87S
ISINDE000SW7VNR9
Date issued 2024-03-18
Strike 340
Maturity 2025-03-21 (311 Days)
Parity 40 : 1
Emission price 0.94
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.95
Lowest since issue 0.215
Delta0.23x
Omega 4.691
Premium65.5x
Gearing20.75x
Moneyness 0.6224
Difference Strike 128.4
Difference Strike %+37.76%
Spread 0.01
Spread %3.85%
Theoretical value 0.2550
Implied Volatility 49.03 %
Total Loss Probability 88.56 %
Intrinsic value 0.000000
Present value 0.2550
Break even 350.20 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
209.5 EUR
Average target price
251.3 EUR
Spread / Average Target
+19.97%
Consensus
  1. Stock Market
  2. Warrants
  3. 4R87S Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW